A Study on the Outcome and Its Influencing Factors in Patients With Borderline Personality Disorder
An Ambispective Cohort Study on the Prognosis and Its Influencing Factors of Borderline Personality Disorder
1 other identifier
observational
270
1 country
1
Brief Summary
Borderline personality disorder (BPD) is a difficult chronic mental illness. This diagnosis is common in Western countries. Our researchers want to study the outcome and its influencing factors of BPD for the first time in China. Patients with BPD who had been hospitalized in Wuhan Mental Health Center were selected as the subjects. The researchers retrospectively collected the most recent hospitalization data of these patients, and then prospectively follow up them for 2 years to see how their condition will change. By analyzing all data, researchers hope to know deeply about the development law of this illness, and to provide evidence for releasing these patients' suffering.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Oct 2021
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 22, 2021
CompletedFirst Submitted
Initial submission to the registry
August 15, 2023
CompletedFirst Posted
Study publicly available on registry
August 22, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2024
CompletedAugust 22, 2023
August 1, 2023
2.8 years
August 15, 2023
August 15, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
remission rate
The remission rate is calculated as the number of patients who no longer met the diagnostic criteria for BPD for at least 6 months divided by the total number of enrolled patients. The diagnostic tool is ICD-10 (F60.3).
After the first follow-up, patients will be followed up every 6 months, and the total follow-up time was 2 years.
Secondary Outcomes (2)
social disability
After the first follow-up, patients will be followed up every 6 months, and the total follow-up time was 2 years.
quality of life
After the first follow-up, patients will be followed up every 6 months, and the total follow-up time was 2 years.
Eligibility Criteria
Inpatients at the Wuhan Mental Health Center
You may qualify if:
- Diagnosis of BPD based on ICD-10 (F60.3)
You may not qualify if:
- Comorbidity with severe physical disease
- Comorbidity with neurological diseases such as epilepsy
- Comorbidity with mental retardation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Wuhan Mental Health Centre
Wuhan, Hubei, 430014, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Fan Yang, Master
Wuhan Mental Health Centre
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- OTHER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 15, 2023
First Posted
August 22, 2023
Study Start
October 22, 2021
Primary Completion
August 1, 2024
Study Completion
September 1, 2024
Last Updated
August 22, 2023
Record last verified: 2023-08